Nuveen LLC Invests $3.36 Million in Trupanion, Inc. $TRUP

Nuveen LLC purchased a new position in Trupanion, Inc. (NASDAQ:TRUP) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 90,213 shares of the financial services provider’s stock, valued at approximately $3,362,000. Nuveen LLC owned about 0.21% of Trupanion at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Hosking Partners LLP increased its holdings in shares of Trupanion by 86.9% in the 1st quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider’s stock worth $14,821,000 after buying an additional 184,936 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in shares of Trupanion by 11.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,234 shares of the financial services provider’s stock worth $83,000 after acquiring an additional 235 shares during the last quarter. Blueshift Asset Management LLC bought a new stake in shares of Trupanion in the 1st quarter worth approximately $1,407,000. Bayforest Capital Ltd lifted its holdings in shares of Trupanion by 627.4% in the 1st quarter. Bayforest Capital Ltd now owns 28,457 shares of the financial services provider’s stock worth $1,061,000 after acquiring an additional 24,545 shares during the last quarter. Finally, GSA Capital Partners LLP lifted its holdings in shares of Trupanion by 283.9% in the 1st quarter. GSA Capital Partners LLP now owns 49,798 shares of the financial services provider’s stock worth $1,856,000 after acquiring an additional 36,827 shares during the last quarter.

Trupanion Stock Down 0.2%

Shares of NASDAQ TRUP opened at $46.35 on Thursday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.32. Trupanion, Inc. has a 52 week low of $31.00 and a 52 week high of $57.90. The firm’s fifty day moving average is $50.47 and its 200 day moving average is $44.08. The company has a market cap of $1.99 billion, a price-to-earnings ratio of 178.28 and a beta of 1.78.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, August 7th. The financial services provider reported $0.22 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.25. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The company had revenue of $353.56 million for the quarter, compared to the consensus estimate of $346.73 million. During the same period in the previous year, the firm earned ($0.14) earnings per share. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on TRUP shares. Lake Street Capital lowered their price objective on shares of Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a report on Friday, May 2nd. Piper Sandler boosted their price objective on shares of Trupanion from $62.00 to $67.00 and gave the stock an “overweight” rating in a report on Friday, August 8th. Stifel Nicolaus boosted their price objective on shares of Trupanion from $41.00 to $45.00 and gave the stock a “hold” rating in a report on Friday, August 8th. Finally, Cantor Fitzgerald upgraded shares of Trupanion to a “hold” rating in a report on Wednesday, August 13th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and a consensus target price of $54.17.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 2,800 shares of the business’s stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total transaction of $127,568.00. Following the transaction, the chief financial officer directly owned 6,451 shares of the company’s stock, valued at approximately $293,907.56. The trade was a 30.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Brenna Mcgibney sold 2,390 shares of the business’s stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $45.17, for a total transaction of $107,956.30. Following the transaction, the insider directly owned 1,317 shares in the company, valued at approximately $59,488.89. The trade was a 64.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,390 shares of company stock worth $245,238. Insiders own 5.42% of the company’s stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.